Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation & Amortization (IS)EBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsPreferred Shares IssuedProperty, Plant & Equipment (Gross)Shares IssuedShares OutstandingShort-Term Debt issuancesWages, Salaries and Other
Ratios

Coeptis Therapeutics Holdings (COEPW) Shares Outstanding (2021 - 2025)

Historic Shares Outstanding for Coeptis Therapeutics Holdings (COEPW) over the last 5 years, with Q3 2025 value amounting to $5.2 million.

  • Coeptis Therapeutics Holdings' Shares Outstanding rose 15808.31% to $5.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.2 million, marking a year-over-year increase of 15808.31%. This contributed to the annual value of $2.1 million for FY2024, which is 1979.22% up from last year.
  • According to the latest figures from Q3 2025, Coeptis Therapeutics Holdings' Shares Outstanding is $5.2 million, which was up 15808.31% from $4.2 million recorded in Q2 2025.
  • In the past 5 years, Coeptis Therapeutics Holdings' Shares Outstanding ranged from a high of $33.0 million in Q3 2023 and a low of $978342.0 during Q4 2022
  • In the last 5 years, Coeptis Therapeutics Holdings' Shares Outstanding had a median value of $3.4 million in 2025 and averaged $8.4 million.
  • In the last 5 years, Coeptis Therapeutics Holdings' Shares Outstanding skyrocketed by 67627.38% in 2022 and then crashed by 9394.25% in 2024.
  • Quarter analysis of 5 years shows Coeptis Therapeutics Holdings' Shares Outstanding stood at $12.5 million in 2021, then crashed by 92.17% to $978342.0 in 2022, then soared by 80.57% to $1.8 million in 2023, then grew by 19.79% to $2.1 million in 2024, then surged by 143.72% to $5.2 million in 2025.
  • Its last three reported values are $5.2 million in Q3 2025, $4.2 million for Q2 2025, and $3.4 million during Q1 2025.